Drug Type Antibody toxin conjugate |
Synonyms Cintredekin besudotox (USAN/INN), Interleukin-13-PE38QQR immunotoxin, HIL13-PE38QQR + [4] |
Target |
Action inhibitors, stimulants |
Mechanism IL-13R inhibitors(Interleukin 13 receptor inhibitors), Apoptosis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 3 | United States | 01 Feb 2004 | |
Glioblastoma Multiforme | Phase 3 | Canada | 01 Feb 2004 | |
Glioblastoma Multiforme | Phase 3 | Germany | 01 Feb 2004 | |
Glioblastoma Multiforme | Phase 3 | Israel | 01 Feb 2004 | |
Glioblastoma Multiforme | Phase 3 | Netherlands | 01 Feb 2004 | |
Glioblastoma Multiforme | Phase 3 | United Kingdom | 01 Feb 2004 | |
Recurrent Glioblastoma | Phase 3 | United States | 01 Feb 2004 | |
Recurrent Glioblastoma | Phase 3 | Canada | 01 Feb 2004 | |
Recurrent Glioblastoma | Phase 3 | Germany | 01 Feb 2004 | |
Recurrent Glioblastoma | Phase 3 | Israel | 01 Feb 2004 |
Phase 1/2 | 74 | taixiynvts(koxawtprws) = aqcvxqujhr klpflkvhlg (splccuevxs ) | - | 01 Jun 2005 |